2'574 companies found
CRISPR Therapeutics AG
Zug · Since 2013
The core activity of CRISPR Therapeutics is the development of gene therapeutic medicines, particularly through the application of CRISPR-Cas9 technology, to cure diseases at the molecular level. The company focuses on developing medicines for various diseases such as sickle cell anemia, β-thalassemia, cancer, autoimmune disorders, and regenerative medicine.
Cross-border Research Association
Epalinges · Since 2005
The core activity of TAPA EMEA is to improve supply chain security, particularly by connecting experts and developing educational materials to support companies in securing their supply chains.
Cross Research SA
Arzo · Since 1997
The core activity of CROSS Research SA is the conduct of clinical trials, particularly Phase I trials, for the pharmaceutical industry. The company offers services such as central clinical laboratories, analytical laboratories for drug analysis and pharmaceutical laboratories for the development of drugs. It also conducts safety studies, dose-finding studies, bioavailability and bioequivalence studies, as well as specialized studies such as skin adhesion studies and medical device testing.
cryoWrite AG
Basel · Since 2020
The core activity of cryoWrite is the development and manufacture of systems for automated cryo-electron microscopy (cryo-EM) sample preparation. The company focuses on accelerating structure-based drug development by improving the workflow for determining protein structure and enabling new analytical methods.
Cserv GmbH
St. Gallen · Since 2022
The core activity of Cserv is the application of cryogenic technology, i.e. the low-temperature treatment of materials and products to sustainably improve and optimize their properties. This includes the treatment of materials and components in various industries such as mechanical engineering, toolmaking, aerospace, automotive, motor sports, electrical engineering and food technology.
CSL Behring Lengnau AG
Lengnau Be · Since 2017
CSL Behring Lengnau AG is a biotechnology company that develops and manufactures biotherapeutics, including plasma-derived and recombinant products. It focuses on treatments for rare and serious diseases—such as immunoglobulins, specific immunoglobulins and albumin—and conducts research, production and pharmacovigilance activities.
CTI Clinical Trial and Consulting Services Switzerland GmbH
Zurich · Since 2022
CTI Clinical Trial and Consulting Services Switzerland GmbH is a contract research organization (CRO) providing clinical development and consulting services, including study design, clinical project management, monitoring, medical monitoring, and safety/pharmacovigilance. Its services also include laboratory offerings (bioanalytical, biorepository, safety testing), real‑world evidence and late‑phase studies, and a research center conducting Phase I–IV trials.
Strategic Foresight Management GmbH
Aarau · Since 2022
Curtis Instruments AG
Biberist · Since 1996
Curtis Instruments, Inc. is a leading provider of electric vehicle technology, integrated EV systems, and engineering services. The company's core activity is the development, manufacture, and marketing of motor controllers, instruments, power conversion products, and other components for electric vehicles, particularly in the field of electromobility.
Worx Digital People Solutions AG
Zurich · Since 2007
Worx Digital People Solutions AG operates a digital talent platform that turns feedback into continuous employee development. The solution includes multi‑source continuous feedback, personalised action plans and analytics, recruitment assessment tools (questionnaires and ability tests) and integrations such as Microsoft Active Directory.
Cylenk S.A.
Ursy · Since 1982
The core activity of Cylenk is to provide tailored research and development (R&D) services, particularly in the fields of mechatronics, IoT development and IoT cybersecurity. The company supports customers in developing innovative solutions, from idea generation to implementation, and offers flexible capacities to supplement internal teams or act as a complete external partner.
DAC System SA
Manno · Since 2013
The core activity of DAC System is the development and manufacture of solutions for monitoring and controlling radio transmission systems, particularly in the field of broadcasting and critical communication. The company offers specialized products and services to improve the reliability and efficiency of radio transmission systems, including solutions for monitoring antennas, power measurement and predictive maintenance.
DalCor Pharma UK Ltd., Leatherhead, Zweigniederlassung Zug
Zug · Since 2015
The core activity of DalCor Pharmaceuticals is the development and research of medicines for the treatment of cardiovascular diseases, particularly through the application of precision medicine. The company focuses on developing therapies to combat the world's largest health burden, cardiovascular diseases.
DAMIAN PHARMA AG
Walchwil · Since 2014
The core activity of DAMIAN PHARMA AG is the development and marketing of pharmaceutical products, in particular the development of therapies for rare diseases such as Primary Aldosteronism (PA).
Dandelion Science Sàrl
Geneva · Since 2023
The core activity of Dandelion Science is the development of a platform for Generative Neuromodulation, aiming to treat the brain by programming network dynamics, particularly in the treatment of brain injuries and diseases.
Data2time Sàrl
Geneva · Since 2025
Data2time Sàrl is a life data science consultancy that performs data‑driven exploratory analyses and offers algorithm and method prototyping. Services also include setting up data governance and data protection frameworks, quality management systems, development of analysis and reporting pipelines, critical reviews of clinical documents and trainings.
Datacie SA
Lausanne · Since 2020
The core activity of Datacie is the creation of customized, unique and proprietary datasets for companies. To this end, data is collected, extracted and processed from various sources such as corporate websites, news/press releases, legal/patent/trademark databases and regulatory databases. The data is processed using artificial intelligence and human quality assurance to create high-quality and accurate datasets. These datasets can then be used by companies to improve their products and services, open up new markets or optimize existing ones.
Davos Alzheimer's Collaborative (Genève)
Geneva · Since 2021
The core activity of Davos Alzheimer's Collaborative (DAC) is to mobilize a global partnership to combat Alzheimer's disease. This includes, in particular: Improving the early detection and diagnosis of Alzheimer's disease through innovative technologies and research; Preparing health systems worldwide for the introduction of new therapies and treatment methods; Conducting clinical trials and research programs; Collaborating with organizations, governments, and NGOs to promote Alzheimer's research and combat. DAC focuses specifically on developing programs and initiatives that improve the early detection and diagnosis of Alzheimer's disease, such as the Accurate Diagnosis Program and the Early Detection Program.
Davos BioSciences AG
Davos Wolfgang · Since 2019
The core activity of Davos BioSciences AG is to provide biobanking and laboratory services to pharmaceutical companies, particularly in the area of discovery and development of new therapeutic active ingredients and biomarkers, as well as the validation of markers and products to meet regulatory requirements. The focus is on inflammatory skin diseases, allergic diseases and disorders of the immune system, particularly in the field of precision medicine.
dawnsite GmbH
Zurich · Since 2018
The company's core activity encompasses the provision of research, development and other scientific services in the field of data analysis.
How the search works, what each filter means, and how the results come together.
Source: Federal Statistical Office, UID register